VEECO INSTRUMENTS INC.

EXHIBIT 99.1

VEECO REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS

First Quarter 2026 Highlights:

●

Revenue of $158.3 million, compared with $167.3 million in the same period last year

●

GAAP net loss of $(0.3) million, or $(0.01) loss per diluted share, compared with net income of $11.9 million, or $0.20 earnings per diluted share in the same period last year

●

Non-GAAP net income of $8.9 million, or $0.14 per diluted share, compared with $22.2 million, or $0.37 per diluted share in the same period last year

Plainview, N.Y., May 5, 2026 -- Veeco Instruments Inc. (Nasdaq: VECO) today announced financial results for its first quarter ended March 31, 2026. Results are reported in accordance with U.S. generally accepted accounting principles (“GAAP”) and are also reported adjusting for certain items (“Non-GAAP”). A reconciliation between GAAP and Non-GAAP operating results is provided at the end of this press release.

U.S. Dollars in millions, except per share data


GAAP Results	Q1 '26		Q1 '25
Revenue	$	158.3	$	167.3
Net income (loss)	$	(0.3)	$	11.9
Diluted earnings (loss) per share	$	(0.01)	$	0.20


Non-GAAP Results	Q1 '26		Q1 '25
Operating income	$	8.6	$	24.3
Net income	$	8.9	$	22.2
Diluted earnings per share	$	0.14	$	0.37

“Veeco executed well in the first quarter as the industry enters a transformational period driven by rapid expansion of AI data centers and high-performance computing,” said Bill Miller, Ph.D., Veeco’s Chief Executive Officer. “This inflection is driving significant order activity across our portfolio, with particularly strong momentum in silicon photonics as customers scale optical connectivity and power-efficient technologies. Veeco’s differentiated process equipment is increasingly critical to this landscape, positioning us well for sustained, multi-year revenue growth.”

Guidance and Outlook

The following guidance is provided for Veeco’s second quarter 2026:

●

Revenue is expected in the range of $170 million to $190 million

●

GAAP diluted earnings per share are expected in the range of $0.02 to $0.15

●

Non-GAAP diluted earnings per share are expected in the range of $0.20 to $0.32

The following guidance for Veeco’s fiscal year 2026 was previously provided and remains unchanged:

●

Revenue is expected in the range of $740 million to $800 million

●

GAAP diluted earnings per share are expected in the range of $0.83 to $1.17

●

Non-GAAP diluted earnings per share are expected in the range of $1.50 to $1.85

Conference Call Information

A conference call reviewing these results has been scheduled for today, May 5, 2026 starting at 5:00pm ET. To join the call, dial 1-877-407-8029 (toll-free) or 1-201-689-8029. Participants may also access a live webcast of the call by visiting the investor relations section of Veeco's website at ir.veeco.com. A replay of the webcast will be made available on the Veeco website that evening. We will post an accompanying slide presentation to our website prior to the beginning of the call.

About Veeco

Veeco (NASDAQ: VECO) is an innovative manufacturer of semiconductor process equipment. Our laser annealing, ion beam, metal organic chemical vapor deposition (MOCVD), single wafer etch & clean and lithography technologies play an integral role in the fabrication and packaging of advanced semiconductor devices. With equipment designed to optimize performance, yield and cost of ownership, Veeco holds leading technology positions in the markets we serve. To learn more about Veeco’s systems and service offerings, visit www.veeco.com.

No Offer or Solicitation

This communication is not intended to and shall not constitute an offer to purchase or the solicitation of an offer to buy or sell any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made, except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

Forward-looking Statements

This press release contains “forward-looking statements”, within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, as amended, that are based on management’s expectations, estimates, projections and assumptions. Words such as “expects,” “anticipates,” “plans,” “believes,” “scheduled,” “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements include, but are not limited to, those regarding anticipated growth and trends in our businesses and markets, including trends related to artificial intelligence and high-performance computing, industry outlooks and demand drivers, statements regarding the pending merger with Axcelis, the timing of shipments, deliveries and revenue recognition, statements regarding shipments currently being held by U.S. Customs, our investment and growth strategies, our development of new products and technologies, our business outlook for current and future periods, our ongoing transformation initiative and the effects thereof on our operations and financial results, the timing, completion and expected benefits of the proposed transaction and other statements that are not historical facts. These statements and their underlying assumptions are subject to risks and uncertainties and are not guarantees of future performance. Factors that could cause actual results to differ materially from those expressed or implied by such statements include, without limitation: the level of demand for our products; global economic and industry conditions; global trade issues, including the effects of foreign and domestic tariffs and the ongoing trade disputes between the U.S. and China, and changes in trade and export license policies; our dependency on third-party suppliers and outsourcing partners; the timing of customer orders; our ability to develop, deliver and support new products and technologies; our ability to expand our current markets, increase market share and develop new markets; the concentrated nature of our customer base; cybersecurity attacks and our ability to safeguard sensitive information and protect our intellectual property rights in key technologies; the effects of regional or global health epidemics; delays in or failure to complete the proposed transaction, whether due to an inability by either party to satisfy one or more conditions to closing, including an inability to obtain regulatory approval in China, the occurrence of events or changes in circumstances that give rise to the termination of the applicable merger agreement by either party, or otherwise; risks related to the pendency of the proposed transaction and its effect on our business, financial condition, results of operations, cash flows and stock price; our ability to achieve the objectives of operational and strategic initiatives and attract, motivate and retain key employees, including as a result of the proposed transaction; diversion of management time and attention from ordinary course business operations to the proposed transaction and other potential disruptions to our business relating thereto; the variability of

results among products and end-markets, and our ability to accurately forecast future results, market conditions, and customer requirements; the impact of our indebtedness, including our convertible senior notes and our capped call transactions; and other risks and uncertainties described in our SEC filings on Forms 10-K, 10-Q and 8-K, and from time-to-time in our other SEC reports. All forward-looking statements speak only to management’s expectations, estimates, projections and assumptions as of the date of this press release. The Company does not undertake any obligation to update or publicly revise any forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release.

-financial tables attached-

Veeco Contacts:

Investor Relations: Alex Delacroix (516) 528-1020[email protected]

Media: Brenden Wright (410) 984-2610[email protected]

Veeco Instruments Inc. and Subsidiaries
Condensed Consolidated Statements of Operations

(in thousands, except per share amounts)
(unaudited)


		Three months ended March 31,
		2026			2025
Net sales		$	158,341		$	167,292
Cost of sales			102,513			98,825
Gross profit			55,828			68,467
Operating expenses, net:
Research and development			29,875			28,514
Selling, general, and administrative			26,016			25,028
Amortization of intangible assets			705			821
Merger costs			2,012			—
Other operating expense (income), net			(122)			(44)
Total operating expenses, net			58,486			54,319
Operating income (loss)			(2,658)			14,148
Interest income (expense), net			1,175			836
Income (loss) before income taxes			(1,483)			14,984
Income tax expense (benefit)			(1,159)			3,037
Net income (loss)		$	(324)		$	11,947

Income per common share:
Basic		$	(0.01)		$	0.21
Diluted		$	(0.01)		$	0.20

Weighted average number of shares:
Basic			60,414			57,753
Diluted			60,414			60,234

Veeco Instruments Inc. and Subsidiaries
Condensed Consolidated Balance Sheets

(in thousands)


		March 31,			December 31,
		2026			2025
		(unaudited)
Assets
Current assets:
Cash and cash equivalents		$	179,535		$	163,466
Short-term investments			203,796			226,763
Accounts receivable, net			150,521			110,685
Contract assets			21,723			34,838
Inventories			282,231			275,298
Prepaid expenses and other current assets			35,613			34,286
Total current assets			873,419			845,336
Property, plant and equipment, net			107,817			108,646
Operating lease right-of-use assets			24,084			24,606
Intangible assets, net			4,991			5,696
Goodwill			214,964			214,964
Deferred income taxes			124,141			122,935
Other assets			3,553			3,612
Total assets		$	1,352,969		$	1,325,795

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable		$	60,153		$	55,345
Accrued expenses and other current liabilities			52,038			45,503
Contract liabilities			92,731			74,161
Income taxes payable			1,763			3,048
Total current liabilities			206,685			178,057
Deferred income taxes			513			532
Long-term debt			226,253			226,009
Long-term operating lease liabilities			31,140			31,837
Other liabilities			4,716			3,852
Total liabilities			469,307			440,287

Total stockholders’ equity			883,662			885,508
Total liabilities and stockholders’ equity		$	1,352,969		$	1,325,795

Note on Reconciliation Tables

The below tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with GAAP. These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

Reconciliation of GAAP to Non-GAAP Financial Data (Q1 2026)

(in thousands)
(unaudited)


					Non-GAAP Adjustments
					Share-Based
Three months ended March 31, 2026		GAAP			Compensation		Amortization		Other		Non-GAAP
Net sales		$	158,341								$	158,341
Gross profit			55,828		1,511							57,339
Gross margin			35.3	%								36.2	%
Operating expenses			58,486		(7,000)		(705)		(2,012)			48,769
Operating income (loss)			(2,658)		8,511		705		2,012	^		8,570
Net income (loss)			(324)		8,511		705		(16)	^		8,876

^	- See table below for additional details.

Other Non-GAAP Adjustments (Q1 2026)

(in thousands)
(unaudited)


Three months ended March 31, 2026
Merger related expenses	$	2,012
Subtotal		2,012
Non-cash interest expense		244
Non-GAAP tax adjustment *		(2,272)
Total Other	$	(16)

*	- The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.

Net Income per Common Share (Q1 2026)

(in thousands, except per share amounts)
(unaudited)


	Three months ended March 31, 2026
	GAAP		Non-GAAP
Numerator:
Net income (loss) available to common shareholders	$	(324)	$	8,876

Denominator:
Basic weighted average shares outstanding		60,414		60,414
Effect of potentially dilutive share-based awards		—		808
Dilutive effect of 2029 Convertible Senior Notes		—		642
Diluted weighted average shares outstanding		60,414		61,864

Net income (loss) per common share:
Basic	$	(0.01)	$	0.15
Diluted	$	(0.01)	$	0.14

Reconciliation of GAAP to Non-GAAP Financial Data (Q1 2025)

(in thousands)
(unaudited)


					Non-GAAP Adjustments
					Share-based
Three months ended March 31, 2025			GAAP		Compensation		Amortization		Other		Non-GAAP
Net sales		$	167,292								$	167,292
Gross profit			68,467		1,343							69,810
Gross margin			40.9	%								41.7	%
Operating expenses			54,319		(7,865)		(821)		(99)			45,534
Operating income			14,148		9,208		821		99	^		24,276
Net income			11,947		9,208		821		231	^		22,207

^	- See table below for additional details.

Other Non-GAAP Adjustments (Q1 2025)

(in thousands)
(unaudited)


Three months ended March 31, 2025
Other	$	99
Subtotal		99
Non-cash interest expense		257
Non-GAAP tax adjustment *		(125)
Total Other	$	231

*	- The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.

Net Income per Common Share (Q1 2025)

(in thousands, except per share amounts)
(unaudited)


	Three months ended March 31, 2025
	GAAP		Non-GAAP
Numerator:
Net income	$	11,947	$	22,207
Interest expense associated with 2025 and 2027 Convertible Senior Notes		253		273
Net income available to common shareholders	$	12,200	$	22,480

Denominator:
Basic weighted average shares outstanding		57,753		57,753
Effect of potentially dilutive share-based awards		693		693
Dilutive effect of 2025 Convertible Senior Notes		—		174
Dilutive effect of 2027 Convertible Senior Notes⁽¹⁾		1,788		1,354
Diluted weighted average shares outstanding		60,234		59,974

Net income per common share:
Basic	$	0.21	$	0.38
Diluted	$	0.20	$	0.37

(1)

- The non-GAAP incremental dilutive shares includes the impact of the Company’s capped call transaction issued concurrently with our 2027 Notes, and as such, an effective conversion price of $18.46 is used when determining incremental shares to add to the dilutive share count. The GAAP incremental dilutive shares does not include the impact of the Company’s capped call transaction, and as such, an effective conversion price of $13.98 is used when determining incremental shares to add to the dilutive share count.

Reconciliation of GAAP Net Income to Non-GAAP Operating Income (Q1 2026 and 2025)

(in thousands)
(unaudited)


		Three months ended			Three months ended
		March 31, 2026			March 31, 2025
GAAP Net income (loss)		$	(324)		$	11,947
Share-based compensation			8,511			9,208
Amortization			705			821
Merger related expenses			2,012			—
Interest (income) expense, net			(1,175)			(836)
Other			—			99
Income tax expense (benefit)			(1,159)			3,037
Non-GAAP Operating income		$	8,570		$	24,276

Reconciliation of GAAP to Non-GAAP Financial Data (Q2 2026)

(in millions, except per share amounts)

(unaudited)


						Non-GAAP Adjustments
Guidance for the three months ending						Share-based
June 30, 2026	GAAP					Compensation	Amortization	Other	Non-GAAP
Net sales	$	170	-	$	190				$	170	-	$	190
Gross profit		63	-		74	2	—	—		65	-		76
Gross margin		37%	-		39%					38%	-		40%
Operating expenses		62	-		65	(7)	(1)	(2)		52	-		55
Operating income		1	-		10	9	1	2		13	-		22
Net income	$	2	-	$	10	9	1	1	$	12	-	$	21

Income per diluted common share	$	0.02	-	$	0.15				$	0.20	-	$	0.32

Income per Diluted Common Share (Q2 2026)

(in millions, except per share amounts)

(unaudited)


Guidance for the three months ending June 30, 2026	GAAP					Non-GAAP
Numerator:
Net income available to common shareholders	$	2	-	$	10	$	12	-	$	21

Denominator:
Basic weighted average shares outstanding		61	-		61		61	-		61
Effect of potentially dilutive share-based awards		1	-		1		1	-		1
Dilutive effect of 2029 Convertible Senior Notes		2	-		2		2	-		2
Diluted weighted average shares outstanding		64	-		64		64	-		64

Net income per common share:
Income per diluted common share	$	0.02	-	$	0.15	$	0.20	-	$	0.32

Reconciliation of GAAP Net Income to Non-GAAP Operating Income (Q2 2026)

(in millions)
(unaudited)


Guidance for the three months ending June 30, 2026
GAAP Net income		$	2		-		$	10
Share-based compensation			9		-			9
Amortization			1		-			1
Merger related expense			2		-			2
Interest expense (income)			(1)		-			(1)
Income tax expense			1		-			1
Non-GAAP Operating income		$	13		-		$	22

Note: Amounts may not calculate precisely due to rounding.

Reconciliation of GAAP to Non-GAAP Financial Data (FY 2026)

(in millions, except per share amounts)

(unaudited)


						Non-GAAP Adjustments
Guidance for the year ending						Share-based
December 31, 2026	GAAP					Compensation	Amortization	Other	Non-GAAP
Net sales	$	740	-	$	800				$	740	-	$	800
Gross profit		298	-		338	8	—	—		306	-		346
Gross margin		40%	-		42%					41%	-		43%
Operating expenses		244	-		259	(31)	(2)	(6)		205	-		220
Operating income		54	-		79	39	2	6		101	-		126
Net income	$	52	-	$	73	39	2	1	$	94	-	$	115

Income per diluted common share	$	0.83	-	$	1.17				$	1.50	-	$	1.85

Income per Diluted Common Share (FY 2026)

(in millions, except per share amounts)

(unaudited)


Guidance for the year ending December 31, 2026	GAAP					Non-GAAP
Numerator:
Net income available to common shareholders	$	52	-	$	73	$	94	-	$	115

Denominator:
Basic weighted average shares outstanding		61	-		61		61	-		61
Effect of potentially dilutive share-based awards		1	-		1		1	-		1
Dilutive effect of 2029 Convertible Senior Notes		1	-		1		1	-		1
Diluted weighted average shares outstanding		63	-		63		63	-		63

Net income per common share:
Income per diluted common share	$	0.83	-	$	1.17	$	1.50	-	$	1.85

Reconciliation of GAAP Net Income to Non-GAAP Operating Income (FY 2026)

(in millions)
(unaudited)


Guidance for the year ending December 31, 2026
GAAP Net income		$	52		-		$	73
Share-based compensation			39		-			39
Amortization			2		-			2
Merger related expense			6		-			6
Interest expense (income)			(4)		-			(4)
Income tax expense			7		-			10
Non-GAAP Operating income		$	101		-		$	126

Exhibit 99.2

Q1 2026 Financial Results Conference Call May 5th, 2026 Veeco Instruments 1

2 Disclaimer No Offer or Solicitation This communication is not intended to and shall not constitute an offer to purchase or the solicitation of an offer to buy or sell any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made, except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended. Forward-looking Statements This presentation contains “forward-looking statements”, within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, as amended, that are based on management’s expectations, estimates, projections and assumptions. Words such as “expects,” “anticipates,” “plans,” “believes,” “scheduled,” “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements include, but are not limited to, those regarding anticipated growth and trends in our businesses and markets, industry outlooks and demand drivers, including trends related to artificial intelligence and high-performance computing, statements regarding the pending merger with Axcelis, the timing of shipments, deliveries and revenue recognition, statements regarding shipments currently being held by U.S. Customers, our investment and growth strategies, our development of new products and technologies, our business outlook for current and future periods, our ongoing transformation initiative and the effects thereof on our operations and financial results, the timing, completion and expected benefits of the proposed transaction and other statements that are not historical facts. These statements and their underlying assumptions are subject to risks and uncertainties and are not guarantees of future performance. Factors that could cause actual results to differ materially from those expressed or implied by such statements include, without limitation: the level of demand for our products; global economic and industry conditions; global trade issues, including the effects of foreign and domestic tariffs and the ongoing trade disputes between the U.S. and China, and changes in trade and export license policies; our dependency on third-party suppliers and outsourcing partners; the timing of customer orders; our ability to develop, deliver and support new products and technologies; our ability to expand our current markets, increase market share and develop new markets; the concentrated nature of our customer base; cybersecurity attacks and our ability to safeguard sensitive information and protect our intellectual property rights in key technologies; the effects of regional or global health epidemics; delays in or failure to complete the proposed transaction, whether due to an inability by either party to satisfy one or more conditions to closing, including an inability to obtain regulatory approval in China, the occurrence of events or changes in circumstances that give rise to the termination of the applicable merger agreement by either party, or otherwise; risks related to the pendency of the proposed transaction and its effect on our business, financial condition, results of operations, cash flows and stock price; our ability to achieve the objectives of operational and strategic initiatives and attract, motivate and retain key employees, including as a result of the proposed transaction; diversion of management time and attention from ordinary course business operations to the proposed transaction and other potential disruptions to our business relating thereto; the variability of results among products and end-markets, and our ability to accurately forecast future results, market conditions, and customer requirements; the impact of our indebtedness, including our convertible senior notes and our capped call transactions; and other risks and uncertainties described in our SEC filings on Forms 10-K, 10-Q and 8-K, and from time-to-time in our other SEC reports. All forward-looking statements speak only to management’s expectations, estimates, projections and assumptions as of the date of this presentation. The Company does not undertake any obligation to update or publicly revise any forward-looking statements to reflect events, circumstances or changes in expectations after the date of this presentation. Non-GAAP Financial Measures This presentation also includes references to financial measures that are calculated and presented on the basis of methodologies other than in accordance with generally accepted accounting principles in the United States of America (“GAAP”). These non-GAAP measures include, but are not limited to, non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating income, non-GAAP net income and non-GAAP diluted earnings per share. Any non-GAAP financial measures used in this presentation are in addition to, and should not be considered superior to, or a substitute for, financial statements prepared in accordance with GAAP. Non-GAAP financial measures should not be considered in isolation or as an alternative to financial statements prepared in accordance with GAAP and are subject to significant inherent limitations. We believe these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Veeco's financial condition and results of operations. The non-GAAP measures presented herein should not be comparable to similar non-GAAP measures presented by other companies. These non-GAAP financial measures are subject to inherent limitations as they reflect the exercise of judgments by management about which expense and income are excluded or included in determining these non-GAAP financial measures. A reconciliation of non-GAAP financial measures used in this presentation to the most directly comparable GAAP financial measures is included in the Appendix.

Bill Miller, Ph.D. CEO Overview 3

4 Q1 2026 Highlights 1. Major industry inflection with AI infrastructure build-out 2. Order activity acceleration from back-half of 2025 into Q1 2026 3. Stronger than expected revenue opportunity for InP laser manufacturing 4. Operational manufacturing footprint expansion 5. Reiterate FY 2026 guide with increased visibility into 2027 Revenue $158M Non-GAAP Operating Income $9M Non-GAAP EPS 0.14₵ Key Takeaways

5 Veeco’s Critical Role in Semi Manufacturing Deposition Lithography Etch Ion Implant Anneal Inspection Adv. Packaging IBD 300 IBD EUV LSA NSA Wet Processing Litho New products FRONT END BACK END Driving business today Representative Process Steps Key: IBD: Ion Beam Deposition EUV: Extreme ultraviolet LSA: Laser Spike Annealing NSA: Nanosecond Annealing System Tier 1 Customer Current Evaluations LSA Logic 1 Memory 1 NSA Logic 2 Memory 0 IBD300 Logic 0 Memory 2 Note: Opportunity for forecasted revenue of $30M-$60M per application at 100K wspm

6 Semi SAM Expansion To Drive Outperformance Key Process 2026 2030 Annealing Laser Spike Annealing (LSA) ~$800M ~$1.3B Nanosecond Annealing (NSA) Ion Beam Deposition IBD300 Front End Semi ~$120M ~$500M IBD EUV Mask Blanks & Pellicles Advanced Packaging Wet Processing and Lithography ~$600M ~$1.0B Veeco’s Technology Enables Gate-All-Around, High-Bandwidth Memory, EUV Lithography and Advanced Packaging Source: Veeco Served Available Market based on TrendFocus, Gartner, Yole Group and internal analysis 2026 2030 Total Served Available Market Annealing IBD Advanced Packaging Services & Other Projected ~12% CAGR ~$1.7B ~$3.0B

7 Veeco’s Critical Role in Compound Semi: Indium Phosphide Laser Solutions Repeat cycle depending on device Epitaxy Patterning Metallization Anneal / Cleave Etch Laser Facet Coating Lumina® MOCVD InP Platform Size of bubble represents approximate market opportunity Veeco Provides Differentiated Solutions for Key Steps in manufacturing InP Lasers Driven by AI Infrastructure Cumulative ~$2B Total Market Opportunity over the next several years WaferEtch® / WaferStorm® Wet Processing Spector® Ion Beam Deposition

8 Compound Semi Projected SAM Growth Source: Veeco Served Available Market based on TrendFocus, Gartner, Yole Group and internal analysis Key Driver 2026 2030 Silicon Photonics (InP Lasers) • Lumina® MOCVD InP platform • WaferEtch® and WaferStorm® systems • Spector® IBD for laser diode facets coatings ~$300M ~$700M Other Photonics • Lumina® MOCVD platform for red MicroLED and solar cells • Propel® 300 for GaN on Si MicroLED for AR / VR and optical communications ~$300M ~$550M GaN Power • Propel® single wafer MOCVD platform for 200mm and 300mm GaN • Propel® 300mm GaN on Si evaluation system at leading IDM customer • Received Propel® 300mm pilot line order in 2H ‘25 ~$150M ~$250M Veeco’s Technology Supports AI, Power Efficiency, and Advanced Connectivity, which are Reshaping the Industry 2026 2030 Total Served Available Market GaN Power InP Lasers Other Photonics RF & Other Services Projected ~15% CAGR ~$1.0B ~$2.0B

John Kiernan CFO Overview 9

10 Revenue by Market Revenue by Region Scientific & Other Semiconductor Compound Semiconductor Data Storage ROW is negligible 13% 12% 6% 69% 20% 13% 10% 57% United States EMEA APAC China $158M Revenue Trend ($M) Q1 25 Q4 25 Q1 26 Semiconductor 124 111 109 Compound Semi 14 20 19 Data Storage 7 10 10 Scientific & Other 22 24 20 Total 167 165 158 Revenue Trend ($M) Q1 25 Q4 25 Q1 26 APAC 60 90 90 USA 24 29 32 China 71 38 20 EMEA & ROW 12 8 16 Total 167 165 158 Q1 2026 Revenue by Market & Region Amounts may not calculate precisely due to rounding.

11 Amounts may not calculate precisely due to rounding. A reconciliation of GAAP to Non-GAAP financial measures can be found in the backup section of this presentation. In millions (except per share amounts) GAAP Non-GAAP Non-GAAP Q4 25 Q1 26 Q4 25 Q1 26 Q1 26 Guidance (as of Feb. 25th, 2026) Revenue $165.0 $158.3 $165.0 $158.3 $150M - $170M Gross Profit 60.5 55.8 62.3 57.3 Gross Margin 36.7% 35.3% 37.7% 36.2% 37% - 38% Operating Expenses 61.9 58.5 48.5 48.8 $48M - $50M Operating Income (Loss) (1.4) (2.7) 13.8 8.6 Net Income (Loss) 1.1 (0.3) 14.7 8.9 $9M - $15M Diluted Earnings Per Share (Loss) 0.02 (0.01) 0.24 0.14 $0.14 - $0.24 Diluted Shares 61.5 60.4 61.5 61.9 Q1 2026 Operating Results

12 Amounts may not calculate precisely due to rounding. A reconciliation of GAAP to Non-GAAP financial measures can be found in the backup section of this presentation. Balance Sheet and Cash Flow Highlights $ millions Q4 2025 Q1 2026 Cash & Short-Term Investments 390 383 Accounts Receivable 111 151 Inventories 275 282 Accounts Payable 55 60 Long-Term Debt 226 226 Cash Flow from Operations 25 8 Capital Expenditures 3 5 DSO (days) 60 86 DIO (days) 232 245 DPO (days) 48 54

13 Q2 & FY 2026 Outlook A reconciliation of GAAP to Non-GAAP financial measures can be found in the backup section of this presentation. Q2 2026 FY 2026 GAAP Non-GAAP GAAP Non-GAAP Revenue $170M - $190M $170M - $190M $740M - $800M $740M - $800M Gross Margin 37% - 39% 38% - 40% 40% - 42% 41% - 43% Operating Expenses $62M - $65M $52M - $55M $244M - $259M $205M - $220M Net Income $2M – $10M $12M - $21M $52M - $73M $94M - $115M Diluted Earnings Per Share $0.02 – $0.15 $0.20 - $0.32 $0.83 - $1.17 $1.50 - $1.85

Q&A 14

Backup & Financial Tables 15

16 $M 2022 2023 2024 2025 2026 FY Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Q1 Semi 369.4 93.1 106.3 98.2 115.2 412.7 120.4 109.9 124.1 112.1 466.6 123.8 123.9 118.3 110.5 476.6 109.0 Compound Semi 121.2 21.2 24.1 25.7 16.3 87.3 21.0 18.2 15.6 22.8 77.6 14.4 14.2 10.9 20.1 59.6 18.8 Data Storage 87.5 21.5 13.9 34.0 19.1 88.5 18.0 34.0 32.8 14.1 98.9 6.7 12.4 10.0 10.2 39.2 10.2 Scientific & Other 68.0 17.7 17.4 19.6 23.4 78.0 15.1 13.8 12.4 33.0 74.2 22.4 15.7 26.7 24.2 88.9 20.3 Total 646.1 153.5 161.6 177.4 173.9 666.4 174.5 175.9 184.8 182.1 717.3 167.3 166.1 165.9 165.0 664.3 158.3 Historical Revenue by End-Market Amounts may not calculate precisely due to rounding.

17 2029 Convertible Notes Outstanding Convertible Notes Due June 2029 Principal Amount Carrying Value Coupon Annual Cash Interest Annual Non-Cash Interest Initial Conversion Price 230M 226M 2.875% 6.6M 1.1M 29.22 As of March 31, 2026 * The Company is required to settle the principal amount of the 2029 Convertible Notes in cash,and has the option to settle the excess above principal in any combination of cash or shares. As such, only “in-the-money” shares above the implied conversion price of $29.22 are added to the diluted share count, and there is no interest expense add-back to the numerator for purposes of calculating diluted EPS. Effect of Convertible Notes on Diluted EPS (GAAP and Non-GAAP)* Average Stock Price per Common Share Incremental Dilutive Shares (in thousands) $29.00 - $30.00 205 $35.00 1,300 $40.00 2,121 $45.00 2,760 $50.00 3,271 $55.00 3,689 $60.00 4,037

18 Note on Reconciliation Tables These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, incremental transaction-related compensation, and certain integration costs. These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors' operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating Income, which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

Supplemental Information—GAAP to Non-GAAP Reconciliation $ millions Q4 25 Q1 26 Net sales $165.0 $158.3 GAAP gross profit 60.5 55.8 GAAP gross margin 36.7% 35.3% Add: Share-based comp 1.7 1.5 Non-GAAP gross profit $62.3 $57.3 Non-GAAP gross margin 37.7% 36.2% $ millions Q4 25 Q1 26 GAAP Net income (loss) $1.1 ($0.3) Add: Share-based comp 9.0 8.5 Add: Amortization 0.7 0.7 Add: Merger related expenses 6.3 2.0 Add: Changes in contingent consideration (0.9) - Add: Interest expense (income) (1.3) (1.2) Add: Tax expense (benefit) (1.2) (1.2) Non-GAAP operating income $13.8 $8.6 $ millions, except per share amounts Q4 25 Q1 26 GAAP Basic weighted average shares 60.1 60.4 GAAP Diluted weighted average shares 61.5 60.4 GAAP Basic EPS $0.02 ($0.01) GAAP Diluted EPS $0.02 ($0.01) GAAP Net income (loss) $1.1 ($0.3) Add: Share-based comp 9.0 8.5 Add: Amortization 0.7 0.7 Add: Merger related expenses 6.3 2.0 Add: Changes in contingent consideration (0.9) - Add: Non-cash interest expense 0.3 0.2 Add: Tax adjustment from GAAP to Non-GAAP (1.8) (2.3) Non-GAAP net income 14.7 8.9 Non-GAAP basic EPS $0.24 $0.15 Non-GAAP diluted EPS $0.24 $0.14 Non-GAAP basic weighted average shares 60.1 60.4 Non-GAAP diluted weighted average shares 61.5 61.9 $ millions Q4 25 Q1 26 GAAP operating expenses $61.9 $58.5 Share-based compensation (7.3) (7.0) Amortization (0.7) (0.7) Merger related expenses (6.3) (2.0) Changes in contingent consideration and other 0.9 - Non-GAAP operating expenses $48.5 $48.8 Amounts may not calculate precisely due to rounding. 19

$ millions Non-GAAP Adjustments GAAP Share-Based Compensation Amortization Other Non-GAAP Net Sales $158.3 $158.3 Gross Profit 55.8 1.5 — — 57.3 Gross Margin 35.3% 36.2% Operating Expenses $58.5 (7.0) (0.7) (2.0) $48.8 Operating Income (Loss) ($2.7) 8.5 0.7 2.0 $8.6 Net Income (Loss) ($0.3) 8.5 0.7 0.0 $8.9 Q1 2026 Actual: GAAP to Non-GAAP Reconciliation Income per Diluted Common Share GAAP Non-GAAP Net Income (Loss) available to common shareholders ($0.3) $8.9 Basic weighted average common shares 60.4 60.4 Add: Dilutive effect of share-based awards — 0.8 Add: Dilutive effect of 2029 Convertible Senior Notes — 0.6 Diluted weighted average common shares 60.4 61.9 Basic income (loss) per common share ($0.01) $0.15 Diluted income (loss) per common share ($0.01) $0.14 Other Non-GAAP Adjustments Merger related expenses 2.0 Subtotal 2.0 Non-cash Interest Expense 0.2 Non-GAAP tax adjustment (2.3) Total Other $0.0 Amounts may not calculate precisely due to rounding.

Reconciliation of GAAP to non-GAAP Financial Data Non-GAAP Adjustments GAAP Share-Based Compensation Amortization Other Non-GAAP Net Sales $170–$190 $170–$190 Gross Profit 63–74 2 — — 65–76 Gross Margin 37%–39% 38%–40% Operating Expenses $62–$65 (7) (1) (2) $52–$55 Operating Income $1–$10 9 1 2 $13–$22 Net Income $2–$10 9 1 1 $12–$21 Income per Diluted Share $0.02–$0.15 $0.20–$0.32 Q2 2026 Guidance ($ millions, except per share amounts) Reconciliation of GAAP Net Income to non-GAAP Operating Income GAAP Net Income $2–$10 Share-Based Compensation 9 Amortization 1 Merger related expenses 2 Interest expense (income) (1) Income tax expense (benefit) 1 Non-GAAP Operating Income $13–$22 Amounts may not calculate precisely due to rounding. Income per Diluted Common Share GAAP Non-GAAP Net income available to common shareholders $2–$10 $12–$21 Basic weighted average common shares 61 61 Add: Dilutive effect of share-based awards 1 1 Add: Dilutive effect of 2029 Convertible Senior Notes 2 2 Diluted weighted average common shares 64 64 Income per diluted common share $0.02-$0.15 $0.20-$0.32

Reconciliation of GAAP to non-GAAP Financial Data Non-GAAP Adjustments GAAP Share-Based Compensation Amortization Other Non-GAAP Net Sales $740–$800 $740–$800 Gross Profit 298–338 8 — — 306–346 Gross Margin 40%–42% 41%–43% Operating Expenses $244–$259 (31) (2) (6) $205–$220 Operating Income $54–$79 39 2 6 $101–$126 Net Income $52–$73 39 2 1 $94–$115 Income per Diluted Share $0.83–$1.17 $1.50–$1.85 FY 2026 Guidance ($ millions, except per share amounts) Reconciliation of GAAP Net Income to non-GAAP Operating Income GAAP Net Income $52–$73 Share-Based Compensation 39 Amortization 2 Merger related expenses 6 Interest expense (income) (4) Income tax expense (benefit) 7-10 Non-GAAP Operating Income $101–$126 Amounts may not calculate precisely due to rounding. Income per Diluted Common Share GAAP Non-GAAP Net income available to common shareholders $52–$73 $94–$115 Basic weighted average common shares 61 61 Add: Dilutive effect of share-based awards 1 1 Add: Dilutive effect of 2029 Convertible Senior Notes 1 1 Diluted weighted average common shares 63 63 Income per diluted common share $0.83-$1.17 $1.50-$1.85


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	VECO	The NASDAQ Global Select Market


Exhibit		Description

99.1		Press release issued by Veeco dated May 5, 2026

99.2		Veeco Q1 2026 Conference Call Presentation May 5, 2026

104		Cover Page Interactive Data File (formatted as inline XBRL).


May 5, 2026	VEECO INSTRUMENTS INC.

	By:	/s/ Kirk Mackey
	Name: Kirk Mackey
	Title: Vice President, General Counsel


Delaware (State or other jurisdiction of incorporation)	0-16244 (Commission File Number)	11-2989601 (IRS Employer Identification No.)